![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C12N 9/40 | (2006.01) |
A61K 38/00 | (2006.01) | ||
A61K 38/47 | (2006.01) | ||
C07K 14/705 | (2006.01) | ||
C12P 21/00 | (2006.01) |
(11) | Number of the document | 3060660 |
(13) | Kind of document | T |
(96) | European patent application number | 14796346.6 |
Date of filing the European patent application | 2014-10-22 | |
(97) | Date of publication of the European application | 2016-08-31 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
(46) | Date of publication of the claims translation | 2021-07-26 |
(86) | Number | PCT/US2014/061789 |
Date | 2014-10-22 |
(87) | Number | WO 2015/061464 |
Date | 2015-04-30 |
(30) | Number | Date | Country code |
201361894879 P | 2013-10-23 | US | |
201361901942 P | 2013-11-08 | US |
(72) |
LEE, Karen , US
HWANG, Christopher , US
DEMARIA, Christine , US
|
(73) |
Genzyme Corporation ,
50 Binney Street, Cambridge, MA 02142,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Rekombinantiniai glikoproteinai ir jų naudojimas |
RECOMBINANT GLYCOPROTEINS AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2024-09-19 | 11 | 289.00 EUR |
2025-10-22 |